Improving Adherence to HIV Quality of Care Indicators in Persons With Opioid Dependence: The Role of Buprenorphine
Authors:
- P Todd KorthuisPKP Todd Korthuis
- David A FiellinDFDavid A Fiellin
- Paula J LumPLPaula J Lum
- Frederick L AlticeFAFrederick L Altice
- Joshua BovermanJBJoshua Boverman
- 1 March 2011
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 56 (Supplement) , S83-S90
Abstract
Opioid-dependent HIV-infected patients are less likely to receive HIV quality of care indicators (QIs) compared with nondependent patients. Buprenorphine/naloxone maintenance therapy (bup/nx) could affect the quality of HIV care for opioid-dependent patients. We abstracted 16 QIs from medical records at nine HIV clinics 12 months before and after initiation of bup/nx versus other treatment for opioid dependence. Summary quality scores (number of QIs received/number eligible × 100) were calculated. We compared change in QIs and summary quality scores in patients receiving bup/nx versus other participants. One hundred ninety-four of 268 participants (72%) received bup/nx and 74 (28%) received other treatment. Mean summary quality scores increased over 12 months for participants receiving bup/nx (45.6% to 51.6%, P < 0.001) but not other treatment (48.6% to 47.8%, P = 0.788). Bup/nx participants experienced improvements in six of 16 HIV QIs versus three of 16 QIs in other participants. Improvements were mostly in preventive and monitoring care domains. In multivariable analysis, bup/nx was associated with improved summary quality score (β 8.55; 95% confidence interval, 2.06-15.0). In this observational cohort study, HIV-infected patients with opioid dependence received approximately half of HIV QIs at baseline. Buprenorphine treatment was associated with improvement in HIV QIs at 12 months. Integration of bup/nx into HIV clinics may increase receipt of high-quality HIV care. Further research is required to assess the effect of improved quality of HIV care on clinical outcomes.Keywords
This publication has 39 references indexed in Scilit:
- Substance abuse treatment in human immunodeficiency virus: The role of patient–provider discussionsJournal of Substance Abuse Treatment, 2008
- Initial evidence for the reliability and validity of a “Lite” version of the Addiction Severity IndexDrug and Alcohol Dependence, 2007
- Patient Satisfaction with Primary Care Office-Based Buprenorphine/Naloxone TreatmentJournal of General Internal Medicine, 2007
- The Potential Role of Buprenorphine in the Treatment of Opioid Dependence in HIV-Infected Individuals and in HIV Infection PreventionClinical Infectious Diseases, 2006
- Do Increases in Patient Activation Result in Improved Self‐Management Behaviors?Health Services Research, 2006
- Effects of Long‐Term, Medically Supervised, Drug‐Free Treatment and Methadone Maintenance Treatment on Drug Users’ Emergency Department Use and HospitalizationClinical Infectious Diseases, 2003
- Office-Based Treatment of Opiate Addiction with a Sublingual-Tablet Formulation of Buprenorphine and NaloxoneNew England Journal of Medicine, 2003
- Quality Enhancement Research Initiative (QUERI)Medical Care, 2000
- Performance Measures for Guidelines on Preventing Opportunistic Infections in Patients Infected with Human Immunodeficiency VirusClinical Infectious Diseases, 2000
- The CES-D ScaleApplied Psychological Measurement, 1977